1.1.Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotriprer.
D.Delakas,I.Karyotis,G.Daskalopoulos,E.Lianos,E.Mauromanolakis.
J of Endourol 2003, 17: 201-205.
1.2.Membrane androgen binding sites are preferentially expressed in human prostate carcinoma cells.
E.Stathopoulos,C.Dambaki,M.Kampa,P.Theodoropoulos,P.Anezinis,D.Delakas,G.Delides,
E.Castanas.
BMC Clinical Pathology 2003,3: 1-9.
1.3.Symptomatic relief of patients with advanced bladder carcinoma after regional
Intra-arterial chemotherapy.
E.Mantadakis,C.Panagiotidis,D.Delakas,G.Samonis
Anticancer Res 2003, 23(6D): 5143-7.
1.4.Spontaneous perirenal hemorrhage:A 10-year experience at our institution.
G.Daskalopoulos,I.Karyotis,I.Heretis,P.Anezinis,E.Mavromanolakis,D.Delakas
Internat Urol & Nephrol 2004,36: 15-19.
1.5.Electrothermal bipolar coagulation for radical prostatectomies and cystectomies: A preliminary case-controlled study.
G.Daskalopoulos,I.Karyotis,I.Heretis,P.Anezinis,D.Delakas
Internat Urol & Nephrol 2004,36: 181-185.
1.6.Deregulation of p73 isoform equilibrium in benign prostate hyperplasia and prostate cancer.
D.Arvanitis,E.Lianos,N.Soulitzis,D.Delakas,D.Spandidos
Oncology Rep 2004,12:1131-1137.
1.7.Expression analysis of peptide growth factors VEGF, FGF2, TGFB1,EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
N.Soulitzis, I.Karyotis, D.Delakas, D.A. Spandidos
Inter J of Oncol 2006,29: 305-314.
1.8. Μediterranean diet,mononsuturated:saturated`fat ratio and low prostate cancer risk. A myth or a reality?
K.Stamatiou,D.Delakas,F.Sofras
Min Urol & Nefrol 2007,59(1):59-66.
1.9. Pheochromocytoma of the urinary bladder: Report of two cases and review of the literature.
A.Siatelis,C.Konstantinidis,D.Volanis,P.Melidis,V.Leontara,E.Thoma-Tsagli,D.Delakas
Min Urol & Nefrol 2008,60:1-4.
1.10. Post-coital high-flow priapism treated with superselective microcoil embolization
Konstantinidis C,Gekas A,Papatsoris A,KartsaklisP,MourikisD,Delakas D,Sofikitis N
Gaz Med Ital 2010,169:19-21
1.11. Urothelial carcinoma of the sarcomatoid variant in a young patient with spina bifida:a case report and review of the literature
M Nomikos,P Phillipou,C Glava,D Delakas
Cases J 2009,2:9381
1.12. Transrectal Ultrasound-Guided Needle Aspiration of a prostatic Abscess
M Nomikos,I Karyotis,D Volanis,D Delakas
UroToday Inter J 2009,2(6):1944
1.13. Environmental factors and genetic susceptibility promote urinary bladder cancer
D Volanis,T Kadiyska,A Galanis,D Delakas, S Logotheti
Tox Lett 2010,15:193(2):131-7
1.14. Mutational Analysis of the BRAF gene in transitional cell carcinoma of the bladder
I Boulalas,A Zaravinos,D Delakas,D Spandidos
Inter J Biol Mark 2009,24(1):17-21
1.15. Safety of Ultrasound-Guided Transrectal Extended Prostate Biopsy in Patients Receiving Low-dose Aspirin
I Kariotis,P Philippou,D Volanis,E Serafetinides,D Delakas
Inter Br J Urol 2010,36(3):
1.16. Implication of RAF and RKIP Genes in Urinary Bladder Cancer
A Zaravinos,M Chatziioannou,G Lambrou,I Boulalas,D Delakas,D Spandidos
Pathol Oncol Res 2010,
1.17. Plasmacytoid Urothelial Carcinoma of the Bladder: A Rare Malignancy
P Philippou,I Kariotis,D Volanis,A Ploumidis,D Delakas
Urol Inter 2010,
1.18. Prospective Comparative Study of Endoscopic Management OF Bladder Lithiasis:Is Prostate Surgery a Necessary Adjunct?
P Philippou,D Volanis,I Kariotis,E Serafetinides,D Delakas
Urol 2010,
1.19. Statins and prostate cancer:Molecular and clinical aspects
G Papadopoulos,D Delakas,L Nakopoulou,T Kassimatis
Eur JC 2011,
1.20. Activation of RAS Family Genes in Urothelial Carcinoma
I Boulalas,A Zaravinos,I Karyotis,D Delakas,D Spandidos
J Urol 2009,
1.21.Identification of common differentially expressed genes in urinary bladder cancer
A Zaravinos,G Lambrou,I Boulalas,D Delakas,D Spandidos
PLos ONE 2011,6(4):e18135-1-28
1.22.Spotlight on differentially expressed genes in urinary bladder cancer
A Zaravinos,G Lambrou,D Volanis,D Delakas,D Spandidos
PLos ONE 2011,5(6):4,e 18255
1.23. Implication of RAF and RKIP Genes in Urinary Bladder Cancer
A. Zaravinos,M. Chatziioannou,G. Lambrou,I. Boulalas,D. Delakas, D.A. Spandidos
Pathol Oncol Res 2011,17:181-190
1.24. mRNA expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.
Pantazis E,Soulitzis N,Soufla G,Karyotis I,Delakas D,Spandidos DA
J BUON 2011,16(2):323-30
1.25. Expression profile of Rho kinases in urinary bladder cancer
Volanis D, Zaravinos A, Kadiyska T,Delakas D,Spandidos DA
J BUON 2011,16(3):511-521.
1.26. A Computational model for tumor cell membrane tolerance and rigidy limits
G Lambrou,A Zaravinos,M Adamaki,D Delakas,S Vlahopoulos
Proccedings of 10th Inter Workshop on Biomedical Engineering.Kos,5-7 Oct 2011
1.27. Molecular mechanisms in urinary bladder carcinogenesis
Volanis D, Papadopoulos G,Doumas K, Gkialas I,Delakas D
J Buon 2011;16(4):589-601
1.28. Post-esw lithotripsy residual stone fragments:clinical significance and management
O Porfyris,D Delakas
Scand J Urol & Nephrol 2012;early online,1-8
1.29. Expression of miRNAs involved in angiogenesis,tumor cell proliferation,tumorauppressor inhibition,epithelial-mesenchymal transition and activation of metastasis in bladder cancer
A Zaravinos,J Radosicic,G Lambrou,D Volanis,D Delakas,N Stathopoulos,DA Spandidos
J Urol 2012,188(2):615-623
1.30. Role of the angiogenic components, VEGFA,FGF2,OPN and RHOC,in urothelial cell carcinoma of the urinary bladder
Zaravinos A,Volanis D,Lambrou G,Delakas D,Spandidos D
Oncol Rep 2012,28(4):1159-1166
1.31. Association of human herpes,papilloma virus families with bladder cancer
Panagiotakis G,Papadogianni D,Chatziijoannou M,Lasithiotaki I,Delakas D,Spandidos D
Tumour Biol 2012,13:
Ioannis Eleftheropoulos
• 2008 Graduation – Medical degree from the Medical School of Thessaly.
• 2008 Medical Licencure.
• 2008 – 2009 Medical doctor at the 110 Camp Air Force of Larisa, as part of military service.
• 2010 Medical Doctor in Rural Service in Chania, Greece.
• 2010 – 2011 Intern of General Surgery at “General Hospital of Thebes”, Greece.
• 2012 – 2013 Intern of Urology at General Hospital of Melisia “Amalia Fleming”.
• 2013 – 2016 Intern of Urology at General Hospital “Asklepieio Voulas”.
• 11/2014 – 05/2015 Intern of Uro-Pediatric surgery as part of my Urology internship at General Children’s Hospital “Agia Sofia”, Athens, Greece.
• 06/2015 – 12/2015 Intern of Uro-Gynecology surgery as part of my Urology internship at General Hospital “Georgios Gennimatas”, Athens, Greece.
• 2016 Acquisition of the speciality of Urology.
• 2016 – 2017 Extended service at the department of Urology as a Specialist at General Hospital “Asklepieio Voulas” and special training at the department of Extracorporeal Shock Wave Lithotripsy (ESWL).
• 2017 – 2019 Consultant Urologist & Supervisor of the Extracorporeal Lithotripsy at the department of Urology at General Hospital “Asklepieio Voulas”.
• 2019 Observership & Special training at the department of “Female Urology and Pelvic Floor Reconstructive Surgeries” at Imam Reza Hospital, Tabriz University of Medical Sciences.
• 2019 – 2021 Consultant Urologist at “Mediterranean Hospital of Cyprus (MHOC)”, Limassol, Cyprus.
• 2021 – until present Consultant Urologist at the department of Urology at General Hospital “Asklepieio Voulas”.
• 2022 obtained the Master’s Degree in “Minor Pelvic and Perineal Surgery”, Medical School of Larissa, University of Thessaly.
• He is a member of Hellenic Urological Association (HUA), of the European Association of Urology (EAU), of the International Continence Society (ICS) and of the International Neuro-Urology Society (INUS).
• Has attended a lot of Greek and International Conferences, Seminars and Masterclasses.
Gianopoylos
sdaasdasd
organic
ADMINISTRATION OF GENERAL HOSPITAL «ASKLEPIEIO VOULAS»
VOYGIOYKLAKIS EMILIOS Governor - Chairman Διοικητής- Πρόεδρος Δ.Σ. KOULOUVRAKIS ANTONIOS ..... Deputy Governor - Board Member
The clinic shows strong participation in conferences and seminars with presentations of high-level scientific works.
In addition, from November 2022, our clinic participates in the international multicenter prospective study HIPPO, which aims to highlight measures to improve postoperative results after surgical repair of inguinal hernia, together with other excellent centers-hospitals from all over the world.
.
Ophthalmology Clinic
